CUTANEOUS LUPUS
Clinical trials for CUTANEOUS LUPUS explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS LUPUS trials appear
Sign up with your email to follow new studies for CUTANEOUS LUPUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First human tests begin for promising new autoimmune disease drug
Disease control Recruiting nowThis early-stage study is testing a new drug called SAR448501 in adults with moderate-to-severe lupus or rheumatoid arthritis who haven't gotten enough relief from their current treatments. The main goal is to find safe dose levels and see how the drug behaves in the body. About …
Matched conditions: CUTANEOUS LUPUS
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Massive lupus study aims to unlock disease secrets
Knowledge-focused Recruiting nowThis study is creating a long-term registry to track how lupus changes in patients over time. It will follow 1000 people with lupus who are already patients at Duke University, collecting health information and blood samples during their regular doctor visits. The goal is to bett…
Matched conditions: CUTANEOUS LUPUS
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC
-
Tracking autoimmune moms: can we make pregnancy safer?
Knowledge-focused Recruiting nowThis registry aims to understand how autoimmune diseases like lupus and rheumatoid arthritis affect pregnancy. Researchers will follow 1,000 pregnant women with these conditions to identify factors linked to poor outcomes. The study collects information from regular doctor visits…
Matched conditions: CUTANEOUS LUPUS
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:57 UTC